National Academies Press: OpenBook
« Previous: Appendix C: Workshop Agenda
Suggested Citation:"Appendix D: Participants." National Research Council. 2004. Health and Medicine: Challenges for the Chemical Sciences in the 21st Century. Washington, DC: The National Academies Press. doi: 10.17226/10889.
×
Page 44
Suggested Citation:"Appendix D: Participants." National Research Council. 2004. Health and Medicine: Challenges for the Chemical Sciences in the 21st Century. Washington, DC: The National Academies Press. doi: 10.17226/10889.
×
Page 45

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

D Participants Challenges for the Chemical Sciences in the 2ISt Century: Workshop on Health and Medicine William L. Alworth, Tulane University Paul S. Anderson, Bristol-Myers Squibb Company Anand R. Asthagiri, California Institute of Technology John E. Baldwin, Syracuse University Cynthia Bamdad, Minerva Biotechnologies Corporation Georges Belfort, Rensselaer Polytechnic Institute Dale Boger, Scripps Research Institute Ronald Breslow, Columbia University Michael Burkart, University of California, San Diego Cynthia J. Burrows, University of Utah Alison Butler, University of California, Santa Barbara Jeffrey Chalmers, Ohio State University Kevin Chapman, Merck & Co., Inc. Panagiotis D. Christofides, University of California, Los Angeles Steven S. C. Chuang, University of Akron Benjamin F. Cravatt, Scripps Research Institute Samuel Danishefsky, Memorial Sloan-Kettering Cancer Center Nancy A. Da Silva, University of California, Irvine Edward A. Dennis, University of California, San Diego Peter B. Dervan, California Institute of Technology Kenneth M. Doxee, National Science Foundation Christos Georgakis, Polytechnic University Eric M. Gordon, Palantir Consulting Linda G. Griffith, Massachusetts Institute of Technology Peter Gund, Gund Discovery Services Leroy Hood, Institute for Systems Biology Klaudyne Hong, Berlex Biosciences Joel R. Huff, Merck & Co., Inc. 44

APPENDIX D Randy Hungate, Amgen, Inc. Barbara Imperiali, Massachusetts Institute of Technology Gerald F. Joyce, Scripps Research Institute Stephen W. Kaldor, Syrrx, Inc. Sangtae Kim, Eli Lilly and Company Jack F. Kirsh, University of California, Berkeley William F. Koch, National Institute of Standards and Technology Walter Kozumbo, U.S. Air Force Office of Scientific Research Douglas A. Lauffenburger, Massachusetts Institute of Technology Ellen Leahy, Celera Genomics Thomas S. Leyh, Albert Einstein College of Medicine Craig E. Lunte, University of Kansas Sundar Madihally, Oklahoma State University Michael A. Marietta, University of California, Berkeley Luigi Marzilli, Louisiana State University Douglas D. McAbee, California State University, Long Beach Claude F. Meares, University of California, Davis Reginald Morales, University of Puerto Rico, Rio Piedras Thomas H. Morton, University of California, Riverside Larry E. Overman, University of California, Irvine Sean Palecek, University of Wisconsin, Madison C. Dale Poulter, University of Utah Paul J. Reider, Amgen, Inc. Dagmar Ringe, Brandeis University Michael E. Rogers, National Institute of General Medical Sciences W. Mark Saltzman, Yale University Christine E. Schmidt, University of Texas, Austin Peter G. Schultz, Scripps Research Institute John W. Scott, Bristol-Myers Squibb Michael L. Shuler, Cornell University Scott F. Singleton, Rice University Gregory Stephanopoulos, Massachusetts Institute of Technology Basil I. Swanson, Los Alamos National Laboratory James R. Swartz, Stanford University William C. Swope, IBM David H. Thompson, Purdue University Mathew Tirrell, University of California, Santa Barbara Ian A. Tomlinson, Dow Chemical Company Joan S. Valentine, University of California, Los Angeles Christopher T. Walsh, Harvard Medical School Mark K. Weise, Praxair, Inc. Chi-Huey Wong, Scripps Research Institute Michael Zaworotko, University of South Florida 45

Next: Appendix E: Reports From the Breakout Session Groups »
Health and Medicine: Challenges for the Chemical Sciences in the 21st Century Get This Book
×
Buy Paperback | $29.00 Buy Ebook | $23.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The report assesses the current state of chemistry and chemical engineering within the context of drug discovery, disease diagnosis, and disease prevention. Also addressed are chemical and chemical engineering challenges in pharmaceutical synthesis, delivery, and manufacture.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!